grant

Targeting astrocytes to prevent motor decline in aging

Organization SALK INSTITUTE FOR BIOLOGICAL STUDIESLocation La Jolla, UNITED STATESPosted 30 Sept 2024Deadline 31 Aug 2026
NIHUS FederalResearch GrantFY202421+ years oldAD dementiaAddressAdolescentAdolescent YouthAdultAdult HumanAgingAlzheimer Type DementiaAlzheimer disease dementiaAlzheimer sclerosisAlzheimer syndromeAlzheimer'sAlzheimer's DiseaseAlzheimers DementiaAmmon HornArchitectureAstrocytesAstrocytusAstrogliaAutomobile DrivingAutoregulationBasal Transcription FactorBasal transcription factor genesBehaviorBehavioralBiochemicalBlocking AntibodiesBody TissuesBrainBrain Nervous SystemBrain regionCell BodyCell Communication and SignalingCell NucleusCell SignalingCellsCerebellumCognitive DisturbanceCognitive ImpairmentCognitive declineCognitive deficitsCognitive function abnormalCornu AmmonisCorpus StriatumCorpus striatum structureCuesData SetDegenerative Neurologic DisordersDevelopmentDiseaseDisorderDisturbance in cognitionDysfunctionEncephalonEngineering / ArchitectureEnvironmentEnzyme GeneEnzymesExcitatory SynapseExpression SignatureFunctional disorderFutureGene Expression ProfileGene TranscriptionGeneral Transcription Factor GeneGeneral Transcription FactorsGenesGenetic TranscriptionGliaGlial CellsGoalsHealthHippocampusHomeostasisHortega cellHumanHypothalamic structureHypothalamusIFNImmune systemImmunityImpaired cognitionInflammatoryInterferon ReceptorInterferonsIntracellular Communication and SignalingKnock-outKnockoutKolliker's reticulumLinkMediatingMetabolicMiceMice MammalsMicrogliaModern ManMolecularMotorMotor outputMurineMusNerve CellsNerve Transmitter SubstancesNerve UnitNervous System Degenerative DiseasesNeural CellNeural Degenerative DiseasesNeural degenerative DisordersNeurocyteNeurodegenerative DiseasesNeurodegenerative DisordersNeurogliaNeuroglial CellsNeurologic Degenerative ConditionsNeuronsNeurotransmittersNon-neuronal cellNonneuronal cellNucleusOligodendrocytesOligodendrocytusOligodendrogliaOligodendroglia CellOutputParalysis AgitansParkinsonParkinson DiseasePathway interactionsPerformancePeripheralPhysiological HomeostasisPhysiopathologyPrimary ParkinsonismPrimary Senile Degenerative DementiaRNA ExpressionRNA SeqRNA deliveryRNA sequencingRNAseqRecyclingRiskRisk FactorsRoleSignal TransductionSignal Transduction SystemsSignalingSourceStriate BodyStriatumSynapsesSynapticTechniquesTestingTissuesTranscriptionTranscription AlterationTranscription Factor Proto-OncogeneTranscription RegulationTranscription factor genesTranscriptional ControlTranscriptional RegulationTransgenic MiceUp-RegulationUpregulationViralWorkadulthoodage associatedage correlatedage dependentage linkedage relatedage specificagedaged brainaged miceaged mouseaging associatedaging brainaging relatedastrocytic gliabiological signal transductionbrain cellbrain sizecognitive defectscognitive dysfunctioncognitive lossdecline in functiondecline in functional statusdegenerative diseases of motor and sensory neuronsdegenerative neurological diseasesdevelopmentaldrivingelderly miceexperimentexperimental researchexperimental studyexperimentsfunctional declinefunctional status declinegene expression patterngene expression signaturegene inductiongene manipulationgene signaturesgenetic manipulationgenetic signaturegenetically manipulategenetically perturbgitter cellhippocampalhypothalamicinduction of genesinsightjuvenilejuvenile humanmesogliamicroglial cellmicrogliocytemotor deficitnerve cementneurodegenerative illnessneuronalold miceoverexpressoverexpressionpathophysiologypathwayperivascular glial cellpreventpreventingprimary degenerative dementiaresponsesenile dementia of the Alzheimer typesocial rolestriatalsynapsesynapse functionsynaptic functiontooltranscription factortranscriptional profiletranscriptional signaturetranscriptome sequencingtranscriptomic sequencing
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Full Description

PROJECT SUMMARY
In the aged brain, reduced brain size and altered synaptic function are observed in conjunction with motor and

cognitive decline. Despite the importance of identifying what underlies these changes with aging, the molecular

drivers of brain aging and synaptic decline are not well characterized. Recently a role for non-neuronal glial cells,

i.e., astrocytes, microglia, and oligodendrocytes, has been proposed in typical aging. Astrocytes are 15% of brain

cells and provide metabolic support for neurons, perform neurotransmitter recycling, and directly modulate

neuronal synapses in the developing and adult brain. Studies show mouse astrocytes undergo regionally-specific

molecular alterations with aging, with unique transcriptional alterations in astrocytes of the cortex, hippocampus,

striatum, hypothalamus, and cerebellum. In particular, astrocytes of the cerebellum show greater transcriptional

dysregulation than those in cortex, including upregulation of immune system genes in the interferon pathway.

Prior work identified loss of cerebellar neurons in aging, raising the question of whether regionally specialized

changes to cerebellar astrocytes that occur with aging contribute to this neuronal decline. To address this

question RNA sequencing of astrocytes from mouse and human, adult and aged, cerebellum was performed,

identifying Stat1 as a candidate transcriptional regulator of the heightened interferon state of cerebellar

astrocytes in the aged brain. Upregulation of Stat1 occurs concomitant with reduced numbers of excitatory

synapses in cerebellum, and mouse behavioral alterations that are linked to cerebellar function. In Aim 1

experiments are performed to ask if Stat1 is responsible for driving the aged astrocyte signature in the cerebellum

by: decreasing expression of Stat1 in astrocytes in aged mice using viral delivery of the RNA degrading enzyme

CasRx to ask if this is sufficient to revert cerebellar astrocyte aging signatures, and rescue synaptic and

behavioral deficits that are present; knocking-out Stat1 from adult astrocytes to ask if this is sufficient to prevent

the induction of aging-related alterations in cerebellar astrocytes; over-expressing Stat1 in cerebellar astrocytes

in juvenile mice to ask if this is sufficient to drive aging-related transcriptional signatures and motor decline. In

Aim 2 experiments address the cues that drive upregulation of Stat1 and the genes it regulates in aged cerebellar

astrocytes, focusing on signaling through the interferon receptor in astrocytes, and asking if the source of

interferon originates within the brain or in the periphery. These experiments will provide mechanistic insight into

the transcriptional regulation of aging-associated astrocyte states and reveal their contribution to synaptic and

behavioral decline in the aging brain.

Grant Number: 1R21AG091117-01
NIH Institute/Center: NIH

Principal Investigator: Nicola Allen

Sign up free to get the apply link, save to pipeline, and set email alerts.

Sign up free →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →